No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM

Diabetes

Volumn 47, Issue 1, 1998, Pages 125-127

  Djilali Saiah, Idriss ^a   Larger, Etienne ^b   Harfouch Hammoud, Elham ^a   Timsit, José ^a   Clerc, Jérôme ^a   Bertin, Eric ^c   Assan, Roger ^b   Boitard, Christian ^a   Bach, Jean François ^a   Caillat Zucman, Sophie ^a,b  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 2;

ADULT; ARTICLE; AUTOIMMUNITY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; THYROID DISEASE;

EID: 0031985460     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.125     Document Type: Article

References (10)

1. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
2. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vanderwall CL, Schuit F, Gorus FK, Belgian Diabetes Registry, Tosi R, Pozzili P, Todd JA: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:1075-1080, 1996
3. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CA, Bluestone JA: CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1:403-413, 1994
4. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985-988, 1995
5. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction; revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
6. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7.1 and anti-B7.2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181:1145-1155, 1995
7. Donner H, Rau H, Walfich PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K: CTLA-4 Alanine confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus, J Clin Endocrinol Metab 82:143-146, 1997
8. Yanagawa T, Hidaka V, Guimaraes V, Soliman M, Degroot LJ: CTLA-4 gene polymorphism associated with Graves' disease in Caucasian population. J Clin Endocrinol Metab 80:41-45, 1995
9. Huang W, Connor E, Dela Rosa T, Muir A, Schatz D, Silverstein J, Crocket S, She JX, Maclaren NK: Although DR3-DQB1*0201 may be associated with multiple component disease of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in β- cell autolmmunity. J Clin Endocrinol Mrtab 81:2559-2563, 1996
10. Maugendre D, Alizadeh M, Gauthier A, Guilhem I, Pouillaud C, Genetet B, Allannic H, Semana G: Genetic heterogeneity between type la and type 1b insulin- dependent diabetes mellitus: HLA class II and TAP gene analysis. Tissue Antigens 48:540-548, 1996